- Influence of Long-term Gastric Acid Suppression Therapy on the Expression of Serum Gastrin, Chromogranin A, and Ghrelin
-
Chang YW
- KMID: 1062817
- Korean J Gastroenterol.
- 2009 Feb;53(2):126-128.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of Long-term Gastric Acid Suppression Therapy on the Expression of Serum Gastrin, Chromogranin A, and Ghrelin
-
Kim BW, Lee BI, Kim HK, Cho YS, Chae HS, Lee HK, Kim HJ, Han SW
- KMID: 1062810
- Korean J Gastroenterol.
- 2009 Feb;53(2):84-89.
BACKGROUND/AIMS: Long-term use of proton pump inhibitor (PPI) induces hypergastrinemia, which results from the suppression of gastric acid secretion. Hypergastrinemia causes enterochromaffin-like (ECL) cell hyperplasia, which is a predisposing factor... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Usefulness of Plasma Chromogranin A in Pancreatic Neuroendocrine Neoplasm
-
Paik WH, Ryu JK, Song BJ, Kim J, Park JK, Kim YT, Yoon YB
- KMID: 1777564
- J Korean Med Sci.
- 2013 May;28(5):750-754.
- doi: 10.3346/jkms.2013.28.5.750
Chromogranin A (CgA) is widely used as an immunohistochemical marker of neuroendocrine neoplasms and has been measurable in plasma of patients. We assessed the clinical role of plasma CgA in... -
- CITED
-
- Close
- SHARE
-
- Close
